![Neil J. Sandler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Neil J. Sandler
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Symphony Capital LLC
![]() Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York.
6
| Private Company | Investment Managers | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Neil J. Sandler via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Symphony Icon, Inc.
![]() Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Founder Founder | |
Wilkerson Partners LLC | Corporate Officer/Principal Corporate Officer/Principal Founder | ||
AGENUS INC. | Biotechnology | Director/Board Member Director/Board Member | |
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Symphony Dynamo, Inc.
![]() Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Symphony Evolution, Inc.
![]() Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Symphony ViDA, Inc.
![]() Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
University of Pennsylvania | College/University | Masters Business Admin | |
Dartmouth College | College/University | Undergraduate Degree | |
Pavadi Capital LLC
![]() Pavadi Capital LLC Investment ManagersFinance Pavadi Capital LLC (Pavadi) is an independent registered investment advisor and hedge fund manager headquartered in New York City. The firm was co-founded in 2001 by Jeffrey S. Edelman and Zachary S. Sharon, MD. Pavadi provides administrative and investment advisory services to pooled investment vehicles and separately managed accounts. | Investment Managers | Founder | |
Wayne State University (Michigan) | College/University | Doctorate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
Syracuse University College of Law | College/University | Graduate Degree | |
DuPont Merck Pharmaceutical Co.
![]() DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Colgate University | College/University | Undergraduate Degree | |
The City College of New York | College/University | Undergraduate Degree | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member | |
ORGANOVO HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Foundation for Innovative New Diagnostics
![]() Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman | |
Global Alliance for TB Drug Development
![]() Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Director/Board Member | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Fondation Santé | Director/Board Member | ||
Symphony Genisis, Inc.
![]() Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Pharmaceuticals: Major | Director/Board Member | |
Shearman & Sterling LLP
![]() Shearman & Sterling LLP Miscellaneous Commercial ServicesCommercial Services Shearman & Sterling LLP provides legal services. It specializes in appellate litigations, capital markets, corporate governance, environmental, finance, international arbitration, investment funds, litigation, mergers and acquisitions, privatization, real estate, and tax. The company was founded by Thomas Shearman in 1873 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
University of St. Andrews | College/University | Doctorate Degree | |
The Pitcairn Trust Co.
![]() The Pitcairn Trust Co. Investment ManagersFinance The Pitcairn Trust Co. is one of the preeminent multi-family offices, dedicated to helping families protect and grow their substantial financial assets and unique heritage across multiple generations. Pitcairn has been recognized as an innovator and leader in the multi-family office space since its inception in 1923. It delivers objective advice and customized services. | Investment Managers | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 31 |
Zwitserland | 2 |
Griekenland | 2 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 15 |
Consumer Services | 10 |
Finance | 4 |
Commercial Services | 4 |
Health Services | 2 |
Operationeel
Director/Board Member | 18 |
Corporate Officer/Principal | 13 |
Founder | 7 |
Private Equity Investor | 5 |
Chairman | 4 |
Sterkste connecties
Insiders | |
---|---|
Mark Kessel | 18 |
Alastair J. J. Wood | 11 |
Jeff S. Edelman | 7 |
Andrew L. Busser | 7 |
Zach Sharon | 5 |
Darlene R. Backelman | 1 |
- Beurs
- Insiders
- Neil J. Sandler
- Bedrijfsconnecties